NCT02632136

Brief Summary

A newly developed technique of TAP block solely performed by surgeons will be used for postoperative pain relief following laparoscopic total extra peritoneal (TEP) Inguinal hernia repair. Our alternative hypothesis is that laparoscopic-assisted TAP block is better than the periportal wound infiltration in controlling the postoperative pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
86

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2015

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 13, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 16, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

December 16, 2015

Status Verified

December 1, 2015

Enrollment Period

1 year

First QC Date

December 13, 2015

Last Update Submit

December 15, 2015

Conditions

Keywords

LaparoscopicTAP BlockTotal extra peritoneal Inguinal hernia repair

Outcome Measures

Primary Outcomes (1)

  • Pain Scores

    Numerical Analogue score for pain will be recorded at 1, 3, 6 and 24 hours post surgery

    Within 24 hours post surgery

Secondary Outcomes (2)

  • Total opioid usage

    within 24 hours perioperative period

  • Post operative nausea or vomiting

    24 hours post operative period

Study Arms (2)

TAP block group

ACTIVE COMPARATOR

This group will receive 30 ml of 0.25% Bupivacine given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine. They will also receive normal saline injections at port sites, which will be injected before the ports are inserted. 15 ml of normal saline will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports.

Drug: TAP Block Group

Peri-Portal block Group

PLACEBO COMPARATOR

They will receive 0.5% Bupivacaine injections at port sites, which will be injected before the ports are inserted. 15 ml of 0.5% Bupivacaine will be divided in aliquots of 7, 4 and 4 ml. 7 ml will be injected at sub-umblical port side and 4 ml each at the site of other two ports. This group will also receive 30 ml of Normal Saline Injection given as Transversus Abdominus Plane Block under direct Laparascopic view. The TAP block will be injected in the angle of Petit above the anterior superior iliac supine.

Drug: Peri-Portal Block Group

Interventions

Transversus Abdominus Plane (TAP) block: Bupivacaine (30 ml of 0.25%)is injected between internal oblique and transveralis facia. The location of needle and the bleb that is formed after the injection is inspected under diect laparoscopic vision.

Also known as: 0.25% Bupivacaine
TAP block group

15 ml of 0.5% Bupivacaine is injected in the skin and subcutaneous tissue before inserting the ports. 7 ml out of it is injected at sub-umblical port and 4 ml each a the site of other two ports.

Also known as: 0.5% Bupivacaine
Peri-Portal block Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All consecutive ASA grade I-II- III patients undergoing elective unilateral laparoscopic total extra peritoneal (TEP) Inguinal hernia repair
  • Age 18 - 80 yrs, including those who are having recurrent inguinal hernia repair.

You may not qualify if:

  • ASA grade IV, V
  • Bilateral inguinal hernia repair
  • BMI \> 40 kg/m2
  • Converted to open procedures.
  • Conversion to Transabdominal preperitoneal (TAPP) repair
  • Coagulopathy.
  • Allergy to Bupivacaine.
  • Diagnosis of "chronic pain syndrome".
  • Known alcohol or substance abuse within the last 6 months.
  • Daily Opioid intake.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo University Hospital

Castlebar, Mayo, F23 EH39, Ireland

RECRUITING

Related Publications (3)

  • Elamin G, Waters PS, Hamid H, O'Keeffe HM, Waldron RM, Duggan M, Khan W, Barry MK, Khan IZ. Efficacy of a Laparoscopically Delivered Transversus Abdominis Plane Block Technique during Elective Laparoscopic Cholecystectomy: A Prospective, Double-Blind Randomized Trial. J Am Coll Surg. 2015 Aug;221(2):335-44. doi: 10.1016/j.jamcollsurg.2015.03.030. Epub 2015 Mar 27.

    PMID: 25899736BACKGROUND
  • Chetwood A, Agrawal S, Hrouda D, Doyle P. Laparoscopic assisted transversus abdominis plane block: a novel insertion technique during laparoscopic nephrectomy. Anaesthesia. 2011 Apr;66(4):317-8. doi: 10.1111/j.1365-2044.2011.06664.x. No abstract available.

  • Kim MG, Kim SI, Ok SY, Kim SH, Lee SJ, Park SY, Yoo JH, Cho A, Hur KY, Kim MJ. Is transverse abdominis plane block effective following local anesthetic infiltration in laparoscopic totally extraperitoneal hernia repair? Korean J Anesthesiol. 2014 Dec;67(6):398-403. doi: 10.4097/kjae.2014.67.6.398. Epub 2014 Dec 29.

MeSH Terms

Interventions

Bupivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Asif Khan, MBBS, MRCSI

    Mayo University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Asif Khan, MBBS, MRCSI

CONTACT

Iqbal Z Khan, MRCSI, FRCSI

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Registrar, General Surgery

Study Record Dates

First Submitted

December 13, 2015

First Posted

December 16, 2015

Study Start

November 1, 2015

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

December 16, 2015

Record last verified: 2015-12

Data Sharing

IPD Sharing
Will share

Locations